ADC Therapeutics SA
ADCT- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001771910
No open-market purchases or sales by ADC Therapeutics SA insiders were filed in the last 90 days; 113 institutions reported holding it in 13F filings for Q2 2026, worth $86.3M in total; no superinvestor holds it.
13F holders, Q3 2022
Institutional positions in ADC Therapeutics SA as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 66
- +8 vs. Q2 2022
- Shares held
- 36.6M
- +2.15M (+6.2%) vs. Q2 2022
- Total value
- $176.5M
- −$97.5M (−35.6%) vs. Q2 2022
- New holders
- 20
- 9 more added
- Sold out
- 12
- 21 more reduced
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ADCT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 113 | $86.3M |
| Q1 2026 | 118 | $312.9M |
| Q4 2025 | 115 | $292.8M |
| Q3 2025 | 106 | $271.3M |
| Q2 2025 | 86 | $182.1M |
| Q1 2025 | 82 | $77.3M |
| Q4 2024 | 83 | $112.4M |
| Q3 2024 | 77 | $172.9M |
| Q2 2024 | 74 | $163.7M |
| Q1 2024 | 37 | $155.8M |
| Q4 2023 | 38 | $56.4M |
| Q3 2023 | 41 | $35.4M |
| Q2 2023 | 56 | $97.5M |
| Q1 2023 | 59 | $90.9M |
| Q4 2022 | 60 | $149.1M |
| Q3 2022 | 66 | $176.5M |
| Q2 2022 | 58 | $274.1M |
| Q1 2022 | 49 | $501.3M |
| Q4 2021 | 55 | $682.8M |
| Q3 2021 | 53 | $890.6M |
| Q2 2021 | 56 | $816.3M |
| Q1 2021 | 59 | $801.3M |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding ADC Therapeutics SA; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| First Manhattan Co | 200 | $0 | 0.00% | 00.0% | Unchanged |
| Citigroup Inc | 31 | $0 | 0.00% | −2−6.1% | Reduced |
| Salem Investment Counselors Inc | 35 | $0 | 0.00% | 00.0% | Unchanged |
| Parallel Advisors, LLC | 10 | $0 | 0.00% | 00.0% | Unchanged |
| Investors Research Corp | 20 | $0 | 0.00% | 00.0% | Unchanged |
| US Bancorp | 300 | $1.00K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 200 | $1.00K | 0.00% | 00.0% | Unchanged |
| Focused Wealth Management, Inc | 300 | $1.00K | 0.00% | 00.0% | Unchanged |
| Quantbot Technologies LP | 600 | $2.00K | 0.00% | −4,252−87.6% | Reduced |
| BNP Paribas Arbitrage, SA | 726 | $3.50K | 0.00% | +726 | New |
| Group One Trading, L.P. | 900 | $4.00K | 0.00% | +900 | New |
| Cutler Group LP | 1,400 | $6.00K | 0.00% | +1,400 | New |
| Royal Bank of Canada | 1,991 | $9.00K | 0.00% | +500+33.5% | Added |
| Advisor Group Holdings, Inc. | 5,257 | $25.0K | 0.00% | −226−4.1% | Reduced |
| Bank of America Corp | 6,861 | $33.0K | 0.00% | +519+8.2% | Added |
| Simplex Trading, LLC | 8,942 | $43.0K | 0.00% | +8,942 | New |
| Tower Research Capital LLC (TRC) | 9,473 | $46.0K | 0.00% | +8,773+1,253.3% | Added |
| Cypress Capital Group | 10,000 | $48.0K | 0.01% | 00.0% | Unchanged |
| XTX Topco Ltd | 10,368 | $50.0K | 0.01% | +10,368 | New |
| Man Group plc | 10,673 | $51.0K | 0.00% | +10,673 | New |
| Cubist Systematic Strategies, LLC | 11,519 | $56.0K | 0.00% | +11,519 | New |
| Cna Financial Corp | 13,945 | $67.0K | 0.03% | −1,570−10.1% | Reduced |
| PDT Partners, LLC | 15,768 | $76.0K | 0.01% | +15,768 | New |
| Dynamic Technology Lab Private Ltd | 16,957 | $82.0K | 0.01% | +16,957 | New |
| New York Life Investments Alternatives | 17,405 | $84.0K | 0.08% | +17,405 | New |
| Susquehanna International Group, LLP | 17,922 | $86.0K | 0.00% | +17,922 | New |
| Moneta Group Investment Advisors LLC | 19,502 | $94.0K | 0.00% | +50.0% | Added |
| HRT Financial LP | 22,422 | $108.0K | 0.00% | +22,422 | New |
| Rockefeller Capital Management L.P. | 24,971 | $120.0K | 0.00% | −89−0.4% | Reduced |
| Goldman Sachs Group Inc | 28,655 | $138.0K | 0.00% | +28,655 | New |
| Octagon Capital Advisors LP | 30,000 | $145.0K | 0.03% | +30,000 | New |
| Walleye Trading LLC | 33,854 | $163.0K | 0.01% | +33,854 | New |
| Alps Advisors Inc | 38,571 | $186.0K | 0.00% | −6,992−15.3% | Reduced |
| Citadel Advisors LLC | 39,791 | $192.0K | 0.00% | +39,791 | New |
| Trexquant Investment LP | 46,985 | $226.0K | 0.01% | +46,985 | New |
| Woodline Partners LP | 47,567 | $229.0K | 0.00% | +13,726+40.6% | Added |
| Hennion & Walsh Asset Management, Inc. | 51,532 | $248.0K | 0.02% | +12,832+33.2% | Added |
| Employees Retirement System of Texas | 56,227 | $271.0K | 0.00% | −255,773−82.0% | Reduced |
| Renaissance Technologies LLC | 71,100 | $343.0K | 0.00% | −8,800−11.0% | Reduced |
| TD Asset Management Inc | 74,690 | $365.0K | 0.00% | −17,600−19.1% | Reduced |
| Ameriprise Financial Inc | 77,103 | $372.0K | 0.00% | −2,873−3.6% | Reduced |
| Manufacturers Life Insurance Company, The | 77,745 | $380.2K | 0.00% | 00.0% | Unchanged |
| Indie Asset Partners, LLC | 93,839 | $452.0K | 0.46% | −150−0.2% | Reduced |
| Magnetar Financial LLC | 166,868 | $804.0K | 0.01% | −830−0.5% | Reduced |
| Prosight Management, LP | 247,630 | $1.19M | 0.66% | +247,630 | New |
| Morgan Stanley | 283,012 | $1.36M | 0.00% | +77,444+37.7% | Added |
| MPM Oncology Impact Management LP | 334,384 | $1.61M | 0.38% | 00.0% | Unchanged |
| ExodusPoint Capital Management, LP | 369,386 | $1.78M | 0.02% | +230,194+165.4% | Added |
| Matrix Capital Management Company, LP | 400,000 | $1.93M | 0.04% | 00.0% | Unchanged |
| Principal Financial Group Inc | 400,400 | $1.93M | 0.00% | −5,702−1.4% | Reduced |
| Millennium Management LLC | 420,253 | $2.03M | 0.00% | +362,288+625.0% | Added |
| BlackRock Inc. | 427,866 | $2.06M | 0.00% | −38,938−8.3% | Reduced |
| American Century Companies Inc | 451,637 | $2.18M | 0.00% | −1900.0% | Reduced |
| HHLR Advisors, Ltd.SuperinvestorHHLR Advisors (Hillhouse) | 500,000 | $2.41M | 0.06% | 00.0% | Unchanged |
| Walleye Capital LLC | 696,263 | $3.36M | 0.08% | −192,437−21.7% | Reduced |
| Blue Owl Capital Holdings LP | 733,568 | $3.54M | 1.53% | +733,568 | New |
| GCM Grosvenor Holdings, LLC | 735,471 | $3.54M | 0.84% | −562,541−43.3% | Reduced |
| Vantage Consulting Group Inc | 1,186,215 | $5.72M | 3.34% | 00.0% | Unchanged |
| Price T Rowe Associates Inc | 1,190,754 | $5.74M | 0.00% | −770,456−39.3% | Reduced |
| Pictet Asset Management SA | 1,295,018 | $6.24M | 0.01% | 00.0% | Unchanged |
| Eventide Asset Management, LLC | 1,879,959 | $9.06M | 0.18% | 00.0% | Unchanged |
| Deerfield Management Company, L.P. (Series C) | 2,390,297 | $11.5M | 0.23% | +2,390,297 | New |
| Alliancebernstein L.P. | 2,915,160 | $14.1M | 0.01% | −46,464−1.6% | Reduced |
| JPMorgan Chase & Co | 3,416,517 | $16.5M | 0.00% | −37,155−1.1% | Reduced |
| Redmile Group, LLC | 7,512,029 | $36.2M | 1.40% | 00.0% | Unchanged |
| FMR LLC | 7,673,137 | $37.0M | 0.00% | −7,909−0.1% | Reduced |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −86,100−100.0% | Sold out |
| Allianz Asset Management GmbH | 0 | $0 | 0.00% | −61,760−100.0% | Sold out |
| Endurant Capital Management LP | 0 | $0 | 0.00% | −58,967−100.0% | Sold out |
| Zurcher Kantonalbank (Zurich Cantonalbank) | 0 | $0 | 0.00% | −21,408−100.0% | Sold out |
| Lazard Asset Management LLC | 0 | $0 | 0.00% | −16,098−100.0% | Sold out |
| State Street Corp | 0 | $0 | 0.00% | −14,028−100.0% | Sold out |
| Graham Capital Management, L.P. | 0 | $0 | 0.00% | −12,992−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −11,014−100.0% | Sold out |
| Sterling Investment Advisors, Ltd. | 0 | $0 | 0.00% | −1,100−100.0% | Sold out |
| Banque Cantonale Vaudoise | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |
| Assetmark, Inc | 0 | $0 | 0.00% | −365−100.0% | Sold out |
| Venture Visionary Partners LLC | 0 | $0 | 0.00% | −100−100.0% | Sold out |